" ... After years of bitter disagreements between member states and European institutions on genetically modified organisms (GMOs), the Commission has finally decided to hold an unprecedented debate on the future of GMOs in Europe. The president of the Commission, José Manuel Barroso, has promised that the debate will be the first step before a public discussion involving all EU leaders.
But while the discussion might be public, the huge political and economic pressures applied behind the scenes will be very private indeed. The UK is likely to lead a small pack of pro-GMO countries and biotech industries who will push for markets to open up to these risky products. Over the crucial coming months, Greenpeace will keep a watchful eye to ensure that the GMO debate focuses on the interests of consumers, and not purely on the interests of a few multinational companies.
Claims by industry that GM products are good for the environment and a quick-fix solution to world hunger are extravagantly false. Recent studies have shown that growing GMOs actually increases the use of pesticides, contaminates wildlife and the environment, and has unpredictable and irreversible effects on animal and human health.
[ ... ]
In a telling case last week, EU farm ministers refused to authorise a GM potato known as Amflora. A significant majority of 15 member states opposed the product developed by German chemical company BASF. But because of EU rules, the ultimate decision which will affect half a billion European citizens now rests with the Commission.
The problem with the GM potato is that it contains a gene that confers resistance to certain antibiotics. The World Health Organisation (WHO) confirmed in an assessment that this could have serious implications for animal and human health, contradicting previous findings by the European Food Safety Authority (EFSA).
Greenpeace flagged this up to the Commission in 2006 and the European Medicines Agency in London was asked for a third opinion. The antibiotics affected by the gene were found to be of “critical importance” for the treatment of illnesses. EFSA finally recognised its mistake in 2007, but failed to reach the logical conclusion and declare that the product was unsafe. ... "
~ Full article ~
No comments:
Post a Comment